As technology reshapes the way we live and work, trade secrets have become very important. They have unleashed an unprecedented boom in litigation, legislation and media attention. And some investors and companies have found themselves in court or facing damages in the hundreds of millions of dollars. “Trade secrets are the hardest form of IP to…

A coalition of players in the blockchain ecosystem have organized to manage intellectual issues and encourage innovation. The new group, called the Blockchain Intellectual Property Council (BIPC), was officially announced on March 16, 2017, by the Chamber of Digital Commerce at the Blockchain Summit in Washington D.C. This initiative aims to work with the members to…

New York – Joseph I. Rosenbaum, a leading nationally and internationally recognized commercial lawyer, has joined Rimon Law as a Partner in its New York office.  Mr. Rosenbaum joins Rimon from Reed Smith where he was previously a partner. Mr. Rosenbaum represents major multinational companies, emerging growth businesses, as well as small to medium size…

Join Rimon’s Paul Economon on Tuesday September 23, 2014 as he shares his insight on the protection of intellectual property in the early stages of an entreprenureal venture. AccelerateDC is kicking off a Boost Your Startup speaker series this month with a panel discussion on how to protect every entrepreneurs’ money maker: Intellectual Property. For entrepreneurs, intellectual property, especially in the…

So how do biotech ventures govern themselves to run efficiently while complying with state corporate law statutes and state and federal securities laws and regulations imposed by stock exchanges? Frugality that is often self-imposed by scientific founders and then endorsed by the angel investors and venture capital company investors that follow sequentially tend to result…

The public securities markets and the underwriters that lead biotech companies into them dictate a common capital structure suitable for IPOs, which structure almost always deviates starkly from the capital structure of the venture at inception and during its growth phase. Startups frequently commence corporate life structured as limited liability companies with a few founders…

Mindful that this series of articles describes biotech ventures that are ripe for initial public offerings even before launching an income-producing drug product into the commercial market, the paramount objective for all such ventures is to manufacture drugs and commence marketing, sales and distribution thereof as soon as possible. As you read in the previous…

Furthering its reputation for innovation and as a leader in intellectual property protection in Silicon Valley, Rimon is pleased to announce the addition of Robert H. Lee as its Technologist-in-Residence. He is also Research Fellow in Law, Science & Technology at Stanford University. Mr. Lee focuses on intellectual property protection, angel and VC financing and…

For a drug discovery start-up, patent protection of the intellectual property underlying the commercialization pursuit is critically important. If the company is a university or research institution spin-out that obtained licensed rights to intellectual property through a technology transfer, either the licensor or the licensee – as set forth in the License Agreement — must pursue…

A writer (and performer) of the famous “YMCA” song has rocked the music industry by successfully reclaiming the copyrights in many of his works using little known provisions of the Copyright Act of 1976. These provisions allow creators to revoke copyright assignments and again take ownership of their works 35 years after assignment. As more…